{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:28:58Z","timestamp":1791268138154,"version":"4.1.0"},"reference-count":45,"publisher":"Frontiers Media SA","funder":[{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004099","name":"Ligue Contre le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004099","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Liddy Shriver Sarcoma Initiative"},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Physiol."],"DOI":"10.3389\/fphys.2015.00319","type":"journal-article","created":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T01:04:38Z","timestamp":1446685478000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":27,"title":["Bone resorption: an actor of dental and periodontal development?"],"prefix":"10.3389","volume":"6","author":[{"given":"Andrea","family":"Gama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Navet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge William","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Castaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"L\u00e9zot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2015,11,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.bone.2007.07.023","article-title":"Msx2 -\/- transgenic mice develop compound amelogenesis imperfecta, dentinogenesis imperfecta and periodental osteopetrosis","volume":"41","author":"A\u00efoub","year":"2007","journal-title":"Bone"},{"issue":"510","key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2014.00510","article-title":"MSX2 in ameloblast cell fate and activity","volume":"5","author":"Babajko","year":"2014","journal-title":"Front. Physiol."},{"key":"B3","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1515\/jpem-2012-0016","article-title":"Safety and efficacy of a 1-year treatment with zoledronic acid compared with pamidronate in children with osteogenesis imperfecta","volume":"25","author":"Barros","year":"2012","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"B4","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000324787","article-title":"Osteoclasts in the dental microenvironment: a delicate balance controls dental histogenesis","volume":"194","author":"Berdal","year":"2011","journal-title":"Cells Tissues Organs"},{"key":"B5","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1016\/S0140-6736(13)61091-0","article-title":"Risedronate in children with osteogenesis imperfecta: a randomised, double-blind, placebo-controlled trial","volume":"382","author":"Bishop","year":"2013","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.yexcr.2013.12.012","article-title":"Odontoblast physiology","volume":"325","author":"Bleicher","year":"2014","journal-title":"Exp. Cell Res."},{"key":"B7","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00441-007-0499-y","article-title":"Effects of alendronate on tooth eruption and molar root formation in young growing rats","volume":"330","author":"Bradaschia-Correa","year":"2007","journal-title":"Cell Tissue Res."},{"key":"B8","doi-asserted-by":"publisher","first-page":"e80054","DOI":"10.1371\/journal.pone.0080054","article-title":"Role of RANKL (TNFSF11)-dependent osteopetrosis in the dental phenotype of Msx2 null mutant mice","volume":"8","author":"Castaneda","year":"2013","journal-title":"PLoS ONE"},{"key":"B9","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/jcp.22305","article-title":"Bone resorption control of tooth eruption and root morphogenesis: involvement of the receptor activator of NF-\u03baB (RANK)","volume":"226","author":"Castaneda","year":"2011","journal-title":"J. Cell. Physiol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/S1470-2045(13)70277-8","article-title":"Safety and efficacy of denosumab for adults and skeletally mature adolescents with giant cell tumour of bone: interim analysis of an open-label, parallel-group, phase 2 study","volume":"14","author":"Chawla","year":"2013","journal-title":"Lancet Oncol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/wdev.66","article-title":"Diseases of the tooth: the genetic and molecular basis of inherited anomalies affecting the dentition","volume":"2","author":"Cobourne","year":"2013","journal-title":"Wiley Interdiscip. Rev. Dev. Biol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1359\/jbmr.040127","article-title":"Treatment of idiopathic hyperphosphatasia with intensive bisphosphonate therapy","volume":"19","author":"Cundy","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"B13","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1515\/JPEM.2000.13.2.217","article-title":"Effect of alendronate treatment on the clinical picture and bone turnover markers in chronic idiopathic hyperphosphatasia","volume":"13","author":"Demir","year":"2000","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"B14","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1097\/MPH.0000000000000034","article-title":"Golden bullet-denosumab: early rapid response of metastatic giant cell tumor of the bone","volume":"36","author":"Demirsoy","year":"2014","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"5342","DOI":"10.1073\/pnas.1013054108","article-title":"Receptor activator of NF-kappaB (RANK) stimulates the proliferation of epithelial cells of the epidermo-pilosebaceous unit","volume":"108","author":"Duheron","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"B16","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s40272-013-0051-3","article-title":"Giant cell tumor of bone in childhood: clinical aspects and novel therapeutic targets","volume":"16","author":"Federman","year":"2014","journal-title":"Paediatr. Drugs"},{"key":"B17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0070-2153(06)78003-6","article-title":"Advances in defining regulators of cementum development and periodontal regeneration","volume":"78","author":"Foster","year":"2007","journal-title":"Curr. Top. Dev. Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1016\/j.ejca.2013.03.018","article-title":"Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology Group","volume":"49","author":"Goldsby","year":"2013","journal-title":"Eur. J. Cancer"},{"key":"B19","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1177\/00220345980770011201","article-title":"Inhibition of tooth eruption in the rat by a bisphosphonate","volume":"77","author":"Grier","year":"1998","journal-title":"J. Dent. Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1007\/s00223-010-9366-z","article-title":"Administration of the bisphosphonate zoledronic acid during tooth development inhibits tooth eruption and formation and induces dental abnormalities in rats","volume":"86","author":"Hiraga","year":"2010","journal-title":"Calcif. Tissue Int."},{"key":"B21","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1093\/hmg\/3.2.359","article-title":"Genetic linkage of familial expansile osteolysis to chromosome 18q","volume":"3","author":"Hughes","year":"1994","journal-title":"Hum. Mol. Genet."},{"key":"B22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1600-0722.2008.00529.x","article-title":"Effects of bisphosphonates on tooth eruption in children with osteogenesis imperfecta","volume":"116","author":"Kamoun-Goldrat","year":"2008","journal-title":"Eur. J. Oral Sci."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e200","DOI":"10.1200\/jco.2012.46.4255","article-title":"Denosumab treatment of metastatic giant-cell tumor of bone in a 10-year-old girl","volume":"31","author":"Karras","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1210\/en.2012-1928","article-title":"Osteoprotegerin-deficient male mice as a model for severe alveolar bone loss: comparison with RANKL-overexpressing transgenic male mice","volume":"154","author":"Koide","year":"2013","journal-title":"Endocrinology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.bone.2014.08.018","article-title":"Preclinical evidence of potential craniofacial adverse effect of zoledronic acid in pediatric patients with bone malignancies","volume":"68","author":"L\u00e9zot","year":"2014","journal-title":"Bone"},{"key":"B26","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bone.2014.12.011","article-title":"Skeletal consequences of RANKL-blocking antibody (IK22-5) injections during growth: mouse strain disparities and synergic effect with zoledronic acid","volume":"73","author":"L\u00e9zot","year":"2015","journal-title":"Bone"},{"key":"B27","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/jcp.22095","article-title":"Dlx homeobox gene family expression in osteoclasts","volume":"223","author":"L\u00e9zot","year":"2010","journal-title":"J. Cell. Physiol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/0030-4220(90)90145-I","article-title":"Dental abnormalities associated with familial expansile osteolysis: a clinical and radiographic study","volume":"70","author":"Mitchell","year":"1990","journal-title":"Oral Surg. Oral Med. Oral Pathol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/bdrc.20160","article-title":"Cell fate determination during tooth development and regeneration","volume":"87","author":"Mitsiadis","year":"2009","journal-title":"Birth Defects Res. C Embryo Today"},{"key":"B30","doi-asserted-by":"publisher","first-page":"2516","DOI":"10.2353\/ajpath.2010.091224","article-title":"Enamel protein regulation and dental and periodontal physiopathology in MSX2 mutant mice","volume":"177","author":"Molla","year":"2010","journal-title":"Am. J. Pathol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1359\/jbmr.2003.18.8.1381","article-title":"Phenotypic characterization of early onset Paget's disease of bone caused by a 27-bp duplication in the TNFRSF11A gene","volume":"18","author":"Nakatsuka","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"B32","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1080\/03008200290000547","article-title":"Msx1 is a regulator of bone formation during development and postnatal growth: in vivo investigations in a transgenic mouse model","volume":"43","author":"Orestes-Cardoso","year":"2002","journal-title":"Connect. Tissue Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1007\/s00774-010-0198-8","article-title":"Profound hypocalcemia following effective response to zoledronic acid treatment in a patient with juvenile Paget's disease","volume":"28","author":"Polyzos","year":"2010","journal-title":"J. Bone Miner. Metab."},{"key":"B34","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1055\/s-0031-1284365","article-title":"Paget's disease of bone and calcium homeostasis: focus on bisphosphonate treatment","volume":"119","author":"Polyzos","year":"2011","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1002\/jbmr.1868","article-title":"Juvenile paget's disease in an Iranian kindred with vitamin D deficiency and novel homozygous TNFRSF11B mutation","volume":"28","author":"Saki","year":"2013","journal-title":"J. Bone Miner. Res."},{"key":"B36","first-page":"183","article-title":"First use of the RANKL antibody denosumab in osteogenesis imperfecta type VI","volume":"12","author":"Semler","year":"2012","journal-title":"J. Musculoskelet. Neuronal Interact."},{"key":"B37","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1111\/j.1749-6632.2010.05769.x","article-title":"Bisphosphonate use in conditions other than osteoporosis","volume":"1218","author":"Silverman","year":"2011","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"B38","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/BPO.0b013e3182a006a0","article-title":"Musculoskeletal functional outcomes in children with osteogenesis imperfecta: associations with disease severity and pamidronate therapy","volume":"34","author":"Sousa","year":"2014","journal-title":"J. Pediatr. Orthop."},{"key":"B39","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jsbmb.2013.09.008","article-title":"Prevention and treatment of postmenopausal osteoporosis","volume":"142","author":"Tella","year":"2014","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1016\/S0140-6736(13)61531-7","article-title":"Oral bisphosphonates for paediatric osteogenesis imperfecta?","volume":"382","author":"Ward","year":"2013","journal-title":"Lancet"},{"key":"B41","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1196\/annals.1346.016","article-title":"Paget's disease of bone and genetic disorders of RANKL\/OPG\/RANK\/NF-kappaB signaling","volume":"1068","author":"Whyte","year":"2006","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1359\/jbmr.2002.17.1.26","article-title":"Expansile skeletal hyperphosphatasia is caused by a 15-base pair tandem duplication in TNFRSF11A encoding RANK and is allelic to familial expansile osteolysis","volume":"17","author":"Whyte","year":"2002","journal-title":"J. Bone Miner. Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3721","DOI":"10.1021\/jm020819i","article-title":"Highly potent geminal bisphosphonates. From pamidronate disodium (Aredia) to zoledronic acid (Zometa)","volume":"45","author":"Widler","year":"2002","journal-title":"J. Med. Chem."},{"key":"B44","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1601-6343.2009.01439.x","article-title":"Cellular and molecular basis of tooth eruption","volume":"12","author":"Wise","year":"2009","journal-title":"Orthod. Craniofac. Res."},{"key":"B45","first-page":"2981","article-title":"Antineoplastic activity of zoledronic acid and denosumab","volume":"33","author":"Zwolak","year":"2013","journal-title":"Anticancer Res."}],"container-title":["Frontiers in Physiology"],"original-title":[],"deposited":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T16:02:16Z","timestamp":1448985736000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fphys.2015.00319\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,5]]},"references-count":45,"URL":"https:\/\/doi.org\/10.3389\/fphys.2015.00319","relation":{},"ISSN":["1664-042X"],"issn-type":[{"value":"1664-042X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,5]]}}}